Glaucoma Therapeutics Market Size The Glaucoma Therapeutics Market, valued at USD 7.25 million in 2023, is expected to witness steady growth, projected to reach USD 9.62 million by 2031. This trajectory reflects a compound annual growth rate (CAGR) of approximately 3.6% over the forecast period from 2024 to 2031. Glaucoma, characterized by progressive optic nerve damage and vision loss, remains...